PROS1 and viral infectious disease: We selected the RBD as the antigen because this region of the S protein is the dominant target for neutralizing response in COVID-19 infection [37,45,46,47] and because the full-length S protein of other coronaviruses was associated with enhancement of viral infection or pulmonary toxicity in other studies [26,27,29,30,31,32,33].